Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction

被引:4
|
作者
Nannini, Margherita [1 ]
Astolfi, Annalisa [2 ]
Paterini, Paola [2 ]
Urbini, Milena [2 ]
Santini, Donatella [3 ]
Catena, Fausto [4 ]
Indio, Valentina [5 ]
Casadio, Rita [5 ]
Pinna, Antonio Daniele [6 ]
Biasco, Guido [1 ,2 ]
Pantaleo, Maria A. [1 ,2 ]
机构
[1] Univ Bologna, S Orsola Malpighi Hosp, Dept Hematol & Oncol Sci L&A Seragnoli, I-40138 Bologna, Italy
[2] Univ Bologna, Giorgio Prodi Canc Res Ctr, I-40138 Bologna, Italy
[3] Univ Bologna, S Orsola Malpighi Hosp, Pathol Unit, I-40138 Bologna, Italy
[4] UO Chirurg Urgenza, Aou Parma, Italy
[5] Univ Bologna, Dept Biol, Biocomp Grp, I-40138 Bologna, Italy
[6] Univ Bologna, S Orsola Malpighi Hosp, Transplant Gen & Emergency Surg Dept, I-40138 Bologna, Italy
关键词
gastrointestinal stromal tumors; GIST; KIT; PDGFRA; SDHA; SDHB; SDHC; SDHD; succinate dehydrogenase; wild-type; CARNEY TRIAD; THERAPEUTIC TARGET; DEFICIENT GISTS; MUTATIONS; DISTINCT; KIT; OVEREXPRESSION; PARAGANGLIOMA; STRATAKIS; HYPOXIA;
D O I
10.2217/FON.12.170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
KIT/PDGF receptor-alpha (PDGFRA) wild-type (WT) gastrointestinal stromal tumors (GIST) are characterized by an overexpression of IGF-1 receptor (IGF1R) at the mRNA and protein level. More recently, germline and somatic mutations in succinate dehydrogenase (SDH) subunits A, B and C have been identified in KIT/PDGFRA WT sporadic GIST. Until now, the molecular basis of IGF1R overexpression in KIT/PDGFRA WT GIST has not been explained. In this brief report we investigate the status of the SDH complex at the genomic and protein level in relation to IGF1R expression at the mRNA and protein level in seven KIT/PDGFRA WT sporadic GIST patients. We found that IGF1R was upregulated in all patients harboring SDH mutations or displaying a SDH dysfunction, with respect to KIT/PDGFRA WT GIST without SDH mutations. Western blot analysis confirmed that all patients with an upregulation of IGF1R mRNA had detectable IGF1R protein expression. This report would suggest that IGF1R overexpression in KIT/PDGFRA WT GIST could be driven by the loss-of-function of the SDH mitochondrial complex.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 50 条
  • [31] The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST) (vol 15, 113, 2017)
    Nannini, Margherita
    Urbini, Milena
    Astolf, Annalisa
    Biasco, Guido
    Pantaleo, Maria A.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [32] Succinate Dehydrogenase (SDH) Mutations in Patients with "Wild-Type" (Non-KIT, Non-PDGFRA-Mutated) Gastrointestinal Sarcomas.
    Lodish, M. B.
    Kim, S. Y.
    Janeway, K.
    Ball, E. R.
    Raygada, M.
    Huynh, T.
    Faucz, F.
    Horvath, A.
    Pacak, K.
    Carney, J. A.
    Gaal, J.
    Rustin, P.
    Gimenez-Roqueplo, A.
    Helman, L.
    Stratakis, C. A.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [33] Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors
    Belinsky, Martin G.
    Rink, Lori
    Flieder, Douglas B.
    Jahromi, Mona S.
    Schiffman, Joshua D.
    Godwin, Andrew K.
    von Mehren, Margaret
    GENES CHROMOSOMES & CANCER, 2013, 52 (02): : 214 - 224
  • [34] FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors
    Shi, Eileen
    Chmielecki, Juliann
    Tang, Chih-Min
    Wang, Kai
    Heinrich, Michael C.
    Kang, Guhyun
    Corless, Christopher L.
    Hong, David
    Fero, Katherine E.
    Murphy, James D.
    Fanta, Paul T.
    Ali, Siraj M.
    De Siena, Martina
    Burgoyne, Adam M.
    Movva, Sujana
    Madlensky, Lisa
    Heestand, Gregory M.
    Trent, Jonathan C.
    Kurzrock, Razelle
    Morosini, Deborah
    Ross, Jeffrey S.
    Harismendy, Olivier
    Sicklick, Jason K.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [35] FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors
    Eileen Shi
    Juliann Chmielecki
    Chih-Min Tang
    Kai Wang
    Michael C. Heinrich
    Guhyun Kang
    Christopher L. Corless
    David Hong
    Katherine E. Fero
    James D. Murphy
    Paul T. Fanta
    Siraj M. Ali
    Martina De Siena
    Adam M. Burgoyne
    Sujana Movva
    Lisa Madlensky
    Gregory M. Heestand
    Jonathan C. Trent
    Razelle Kurzrock
    Deborah Morosini
    Jeffrey S. Ross
    Olivier Harismendy
    Jason K. Sicklick
    Journal of Translational Medicine, 14
  • [36] Evaluation of the presence of IGF1R overexpression in wild-type and kinase mutant GI stromal tumors
    Corless, C. L.
    Beadling, C.
    Justusson, E.
    Heinrich, M. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] SDHA Loss-of-Function Mutations in KIT-PDGFRA Wild-Type Gastrointestinal Stromal Tumors Identified by Massively Parallel Sequencing
    Pantaleo, Maria A.
    Astolfi, Annalisa
    Indio, Valentina
    Moore, Richard
    Thiessen, Nina
    Heinrich, Michael C.
    Gnocchi, Chiara
    Santini, Donatella
    Catena, Fausto
    Formica, Serena
    Martelli, Pier Luigi
    Casadio, Rita
    Pession, Andrea
    Biasco, Guido
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (12) : 983 - 987
  • [38] The expression of KIT receptor dimers in gastrointestinal stromal tumors independent of c-kit mutation and SCF expression is associated with high-risk stratification
    Qiu, Cen
    Liu, Xiaohong
    Bai, Chenguang
    Ma, Da Lie
    ONCOLOGY LETTERS, 2012, 4 (04) : 805 - 811
  • [39] RAT GLIOBLASTOMA CELLS EXPRESSING AN ANTISENSE RNA TO THE INSULIN-LIKE GROWTH-FACTOR-I (IGF-1) RECEPTOR ARE NONTUMORIGENIC AND INDUCE REGRESSION OF WILD-TYPE TUMORS
    RESNICOFF, M
    SELL, C
    RUBINI, M
    COPPOLA, D
    AMBROSE, D
    BASERGA, R
    RUBIN, R
    CANCER RESEARCH, 1994, 54 (08) : 2218 - 2222
  • [40] Neurofibromatosis type 1-associated wild-type gastrointestinal stromal tumor treated with anti-IGF-1R monoclonal antibody
    Day, F. L.
    Desai, J.
    Corless, C. L.
    Heinrich, M. C.
    Zalcberg, J.
    MEDICAL ONCOLOGY, 2011, 28 : S162 - S164